Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation.Published in:Journal of Experimental Therapeutics & Oncology, 2012, v. 10, n. 1, p. 1By:Yongbo Liu;Xiaohua Gao;Deeb, Dorrah;Arbab, All S.;Dulchavsky, Scott A.;Gautam, Subhash C.Publication type:Article